Stock data
Boston Scientific Corporation (BSX)
Boston Scientific Corporation (BSX) reported revenue of US$20.07B and net income of US$2.89B for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$20.07B | US$13.85B | US$3.61B | US$2.89B | — |
| 2024 | US$16.75B | US$11.49B | US$2.60B | US$1.85B | — |
| 2023 | US$14.24B | US$9.90B | US$2.34B | US$1.59B | — |
| 2022 | US$12.68B | US$8.73B | US$1.65B | US$698.00M | — |
| 2021 | US$11.89B | US$8.18B | US$1.20B | US$1.04B | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$5.44B | US$905.00M | — |
| 2026-03-31 | US$5.20B | US$1.34B | — |
| 2025-12-31 | US$5.29B | US$670.00M | — |
| 2025-09-30 | US$5.07B | US$755.00M | — |
| 2025-06-30 | US$5.06B | US$795.00M | — |
| 2025-03-31 | US$4.66B | US$672.00M | — |
| 2024-12-31 | US$4.56B | US$563.00M | — |
| 2024-09-30 | US$4.21B | US$468.00M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.